Louisiana Funds
Venture capitalBaton Rouge · Pre-Seed–Series A · 4 people tracked
Investment thesis
Louisiana Funds addresses a gap in early-stage financing within Louisiana, where such investing has historically been sporadic and undercapitalized. The fund targets companies developing commercially promising technologies, emphasizing those originating in Louisiana universities, Louisiana-based companies, and businesses relocating to the state. Focus areas include life sciences such as pharmaceuticals, biotechnology, and agritechnology, as well as information technology and other high-technology opportunities capable of delivering venture capital returns. The fund highlights that Louisiana universities spend over $500 million annually on research in its areas of interest, positioning it to capitalize on university-driven innovation.
Source: firm website, verified Aug 7, 2026.
Team · 4 people
from the firm's website & public directories
What they invest in
from 13 of 21 portfolio companiesBiotech ×6Healthtech ×6SaaS ×4Hardware ×3Medical Devices ×3AI & Machine Learning ×1B2B Marketplaces ×1Cybersecurity ×1
HQs:United States×11Germany×1
Investments · 21 tracked
founders shown can be your intro pathBy year:2022 · 12021 · 12019 · 12017 · 12016 · 12014 · 12013 · 17 dated
Bioceptive develops women's health medical devices, including a patented FDA-approved Cervical Suction Retractor that replaces the tenaculum for gynecological procedures and an IUD inserter, offering single-use disposable instruments aimed at reducing pain during transcervical procedures.
BiotechFemTechHealthtechMedical DevicesNew Orleans, US
Stewart Davis(Executive Officer, Director)Shuchi Khurana(Executive Officer)Benjamin Cappiello(Executive Officer, Director)
BoardJoan Neuscheler(Director)Joseph Lovett(Director)Amit Kumar Rathi(Director)
Co-investorsNew Orleans Startup Fund
Developing intra-articular ion channel modulator therapeutics for osteoarthritis of the knee.
BiotechShreveport, US
William R. Grimes(President and Chief Executive Officer)Stephen Snowdy(Executive Officer, Director)David Waddell(Director)
BoardJoseph Lovett(Director)Richard Babb(Treasurer)Ross Barrett(Director)
Co-investorsRex Health Ventures
Clinical-stage specialty pharma developing a combination drug to treat a range of addictions, licensed from LSU Health Sciences Center.
Co-investorsInnovation CatalystKeiretsu Forum
Esperance develops targeted oncology therapeutics designed to selectively kill cancer cells, including chemotherapy-resistant cells, via a proprietary Cationic Lytic Peptide (CLYP) platform, membrane-disrupting peptides, and antibody drug conjugates.
BiotechHealthtechHouston, US
Hector Alila(Executive Officer, Director)Ross Barrett(Director)Peter Hoang(Director)Sonia Deggs(Executive Officer)Carola Leuschner(Executive Officer)
BoardJoseph Lovett(Director)
Co-investorsResearch Corporation Technologies
Compact micro-tube heat exchanger technology for high-end thermal management in propulsion, electronics, and cooling applications.
Mirata Pharmaceuticals is developing pain-relieving drugs intended to provide the analgesic benefits of opioids without their addictive properties and serious side effects.
BiotechHealthtechPlymouth Meeting, US
John Johnson(Director)Brian Hubbard(Director)Jason Y Zhang(Director)Maurits Geerlings(Director)Matthew Callahan(Executive Officer, Director)
BoardJoseph F Lovett(Director)
Developing 'Epi-drugs' that modulate epigenetic targets for cancer and other diseases.
BiotechBaton Rouge, US
Kenneth J Eilertsen(Director)
BoardJoan P Neuscheler(Executive Officer, Director)Ross Barrett(Director)Charles Oehler(Director)Joseph F Lovett(Executive Officer, Director)
Omnidek offers a business portal that connects to Sage Intacct to synchronize data and provides a library of configurable workflow and process widgets.
Enterprise SoftwareFuture of WorkSaaSBaton Rouge, US
HUEY NGO(Director)AJOY KRISHNAMOORTHY(Director)STEVEN CHRISTOPHER JORDAN(Executive Officer, Director)
BoardRICHARD BABB(Director)inWILLIAM ELLISON(Director)
Co-investorsInnovation Catalyst
Provides solutions for stem cell maintenance, proliferation, differentiation, and large-scale production, including recombinant substrates and antibodies.
Qure4u offers an AI-powered patient engagement platform that automates workflows for healthcare providers, including self-scheduling, digital check-in, arrivals, payment collection, and remote patient monitoring.
Digital HealthHealthtechSaaSBradenton, US
MONICA BOLBJERG(Executive Officer, Director)TORSTEN BOLBJERG(Executive Officer, Director)Monica Bolbjerg(Founder)Torsten Bolbjerg(Co-founder)
Co-investorsAtlanta Technology AngelsSaaS CapitalVolition Capital
Servato develops hardware, software, and predictive analytics for critical infrastructure monitoring and maintenance, including a Platform-as-a-Service that predicts system failures and an Adaptive Charging feature that extends telecom battery life.
EnergyHardwareIoTSaaSNew Orleans, US
Christopher Mangum(Executive Officer, Director)MARK CHRISTOPHER MANGUM(Executive Officer, Director)RONALD LAU(Executive Officer)Chris Mangum(President & CEO)Eric Hedlund(Chief Sales Officer)Dorion Carr(Chief Technology Officer)
Co-investorsNew Orleans Startup FundVenture Center Arkansas
BiotechBoulder, US
Harry Ross(Executive Officer, Director)Donald Schomer(Director)Robert Di Scipio(Director)Mark Lupa(Director)Jesse Aweida(Director)Dan Watkins(Director)
Co-investorsCreathor Ventures
Developed the GraftGrab soft tissue fixation device for ACL reconstruction.
TESA Medical operates an online platform listing medical products from brand manufacturers, offering direct sales, consignment, wholesale, retail, and OEM options.
B2B MarketplacesHealthtechMedical Devices
Frequently asked questions
- How many investments has Louisiana Funds made?
- Louisiana Funds has 21 tracked investments.
- What stage does Louisiana Funds invest at?
- Louisiana Funds invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Louisiana Funds focus on?
- Louisiana Funds focuses on AgTech, Biotech, Cleantech, Cybersecurity, Deep Tech, Digital Health, EdTech, Enterprise Software, Healthtech, Medical Devices.
- Where is Louisiana Funds located?
- Louisiana Funds is headquartered in Baton Rouge, US.
- Who does Louisiana Funds co-invest with?
- Louisiana Funds most often shares deals with Innovation Catalyst, New Orleans Startup Fund, Creathor Ventures, among 9 tracked co-investors.
Similar investors
Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.
Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.
MDI Ventures is the corporate venture capital arm of Telkom Indonesia, investing in and building synergies between technology startups and Indonesian enterprises. It manages a multi-fund platform (including Centauri Fund, Arise, and sector-specific funds) with a portfolio of 80+ companies.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Asia2G (A2G) Capital is a Silicon Valley venture capital firm that invests primarily in early-stage Korean and Asian technology startups seeking to expand globally.